Evidence map›Paper›PMID 21769048›Full record

Trial reportJournal of addiction medicine2011

Effects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteers.

Stephanie C Licata, David M Penetar, Caitlin Ravichandran, John Rodolico, Christopher Palmer, Jeff Berko, Thomas Geaghan, Alison Looby, Erica Peters, Elizabeth Ryan and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of addiction medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Which came first: Cannabis use or deficits in impulse control?Progress in neuro-psychopharmacology & biological psychiatry · 2021
    Review
  10. Possible Benefit and Validity of Supplements for Alcohol Use Disorder.Alcoholism, clinical and experimental research · 2019
    Review
  11. Article
  12. Citicoline in addictive disorders: a review of the literature.The American journal of drug and alcohol abuse · 2014
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Stephanie C LicataBehavioral Psychopharmacology Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA. slicata@mclean.harvard.edu
David M Penetar
Caitlin Ravichandran
John Rodolico
Christopher Palmer
Jeff Berko
Thomas Geaghan
Alison Looby
Erica Peters
Elizabeth Ryan
Perry F Renshaw
Scott E Lukas
Harvard University · USMcLean Hospital · US

Funding

Training In Drug Abuse and Brain ImagingT32DA015036 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI SCOTT E LUKAS · 2002 to 2026
$5.3M
MENTORING IN DRUG ABUSE NEUROIMAGINGK24DA015116 · NIDA · UNIVERSITY OF UTAH · PI RENSHAW, PERRY FRANKLIN · 2002 to 2010
$1.3M
PHARMACOLOGICAL AND BEHAVIORAL INDICES OF DRUG ABUSEK05DA000343 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI LUKAS, SCOTT E · 1997 to 2008
$1.1M
MEDICATION DEVELOPMENT FOR COCAINE ABUSE--CDP CHOLINER01DA011098 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI LUKAS, SCOTT E · 1999 to 2004
$806k
Mentoring in Drug Abuse NeuroimagingK05DA031247 · NIDA · UNIVERSITY OF UTAH · PI RENSHAW, PERRY FRANKLIN · 2011 to 2015
$661k
NIDA NIH HHS DA011098NIDA NIH HHS K05 DA000343NIDA NIH HHS K05DA00343NIDA NIH HHS K05 DA031247NIDA NIH HHS K24 DA015116NIDA NIH HHS K24DA15116NIDA NIH HHS R01 DA011098NIDA NIH HHS T32 DA015036
6 · The paper itself

Abstract

unlabelledMany pharmacotherapies for treating cocaine dependence are aimed at reducing drug effects, alleviating craving, and preventing relapse. We demonstrated previously that citicoline, a compound used to repair neuronal damage in stroke and brain injury, is safe in cocaine-abusing volunteers.

objectivesThis study assessed the effectiveness of an 8-week citicoline treatment period and 4-week follow-up in cocaine-dependent individuals.

methodsTwenty-nine healthy nontreatment-seeking, cocaine-dependent male and female volunteers were randomized in this double-blind, placebo-controlled study, 18 of whom completed the treatment period of the study. Participants took citicoline (500 mg twice daily) or matched placebo each day and recorded the measures of craving and drug use. Participants visited the laboratory twice a week for urine screens and to attend weekly group therapy sessions.

resultsCiticoline had no effect on cocaine craving or total use.

conclusionsAlthough the current preliminary results from this small trial suggest that citicoline is not an effective treatment for heavy cocaine users, further investigation on efficacy citicoline as a treatment for substance dependence in other settings may be warranted.

Indexed as

AdultCocaine-Related DisordersCombined Modality TherapyCytidine Diphosphate CholineDouble-Blind MethodFemaleHumansMaleMiddle AgedNootropic AgentsPsychotherapy, GroupSubstance Abuse DetectionSubstance Withdrawal SyndromeCytidine Diphosphate CholineNootropic Agents

Identifiers

PMID21769048
PMCPMC3140015
OpenAlexW2090166200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.